Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 3053

1.

[Effects of an interprofessional educational program for homecare professionals on building social capital: a trial in an urban area].

Murayama H, Komiyama E, Hirahara S, Nonaka K, Iijima K, Fujiwara Y.

Nihon Koshu Eisei Zasshi. 2019;66(6):317-326. doi: 10.11236/jph.66.6_317. Japanese.

2.

Phase I study of ipatasertib as a single agent and in combination with abiraterone plus prednisolone in Japanese patients with advanced solid tumors.

Doi T, Fujiwara Y, Matsubara N, Tomomatsu J, Iwasa S, Tanaka A, Endo-Tsukude C, Nakagawa S, Takahashi S.

Cancer Chemother Pharmacol. 2019 Jun 21. doi: 10.1007/s00280-019-03882-7. [Epub ahead of print]

PMID:
31227862
3.

[Influence of Bowtie Filter and Patient Positioning on In-plane Dose Distribution and Image Quality in ECG-gated CT].

Minami K, Matsubara K, Hayashi Y, Fujiwara Y, Morimoto K, Kobatake T.

Nihon Hoshasen Gijutsu Gakkai Zasshi. 2019;75(6):536-545. doi: 10.6009/jjrt.2019_JSRT_75.6.536. Japanese.

4.

Multiple osteolytic bone and lung metastases from prostate cancer including small cell carcinoma with marked increases in CEA and Pro-GRP.

Okamura S, Fujiwara Y, Nagata K.

Urol Case Rep. 2019 Mar 26;24:100883. doi: 10.1016/j.eucr.2019.100883. eCollection 2019 May.

5.

Impact of Age on Long-Term Survival in Patients with Esophageal Cancer Who Underwent Transthoracic Esophagectomy.

Motoori M, Ito Y, Miyashiro I, Sugimura K, Miyata H, Omori T, Fujiwara Y, Yano M.

Oncology. 2019 Jun 13:1-6. doi: 10.1159/000500604. [Epub ahead of print]

PMID:
31195394
6.

Phase I study of BGT226, a pan-PI3K and mTOR inhibitor, in Japanese patients with advanced solid cancers.

Minami H, Fujiwara Y, Muro K, Sato M, Moriya A.

Cancer Chemother Pharmacol. 2019 Jun 12. doi: 10.1007/s00280-019-03883-6. [Epub ahead of print]

PMID:
31190275
7.

Large Skin Ulcer and Delayed Wound Healing around a Colostomy in a Patient with Metastatic Colorectal Cancer Receiving Vascular Endothelial Growth Factor Receptor-2 Inhibitor Therapy.

Taira K, Nadatani Y, Hirano S, Maeda K, Fujiwara Y.

Case Rep Oncol. 2019 May 16;12(2):370-375. doi: 10.1159/000500412. eCollection 2019 May-Aug.

8.

Difference in central nerve system metastasis during gefitinib or erlotinib therapy in patients with EGFR-mutated non-small cell lung cancer: a retrospective study.

Yoshida K, Kanda S, Shiraishi H, Goto K, Itahashi K, Goto Y, Horinouchi H, Fujiwara Y, Nokihara H, Yamamoto N, Ohe Y.

J Thorac Dis. 2019 Apr;11(4):1347-1354. doi: 10.21037/jtd.2019.03.61.

9.

[Current knowledge of mechanisms of drugs-induced gastrointestinal damage].

Watanabe T, Fujiwara Y.

Nihon Shokakibyo Gakkai Zasshi. 2019;116(6):468-478. doi: 10.11405/nisshoshi.116.468. Japanese. No abstract available.

PMID:
31178576
10.

Transabdominal preperitoneal repair for an adolescent patient with Hunter syndrome: a case report.

Tada Y, Yamamoto M, Sunaguchi T, Uejima C, Tanio A, Murakami Y, Takano S, Sakamoto T, Honjo S, Ashida K, Saito H, Fujiwara Y.

Surg Case Rep. 2019 May 31;5(1):89. doi: 10.1186/s40792-019-0645-2.

11.

Change in arterial tumor perfusion is an early biomarker of lenvatinib efficacy in patients with unresectable hepatocellular carcinoma.

Kuorda H, Abe T, Fujiwara Y, Okamoto T, Yonezawa M, Sato H, Endo K, Oikawa T, Sawara K, Takikawa Y.

World J Gastroenterol. 2019 May 21;25(19):2365-2372. doi: 10.3748/wjg.v25.i19.2365.

12.

The prognostic significance of the comprehensive complication index in patients with gastric cancer.

Shimizu S, Saito H, Kono Y, Murakami Y, Shishido Y, Miyatani K, Matsunaga T, Fukumoto Y, Fujiwara Y.

Surg Today. 2019 May 30. doi: 10.1007/s00595-019-01828-3. [Epub ahead of print]

PMID:
31147763
13.

Phase I study of the indoleamine 2,3-dioxygenase 1 inhibitor navoximod (GDC-0919) as monotherapy and in combination with the PD-L1 inhibitor atezolizumab in Japanese patients with advanced solid tumours.

Ebata T, Shimizu T, Fujiwara Y, Tamura K, Kondo S, Iwasa S, Yonemori K, Shimomura A, Kitano S, Koyama T, Sato N, Nakai K, Inatani M, Yamamoto N.

Invest New Drugs. 2019 May 24. doi: 10.1007/s10637-019-00787-3. [Epub ahead of print]

PMID:
31124055
14.

Have We Found the Key to Unravel Treatment Development Lags for Rare Cancers?: MASTER KEY Project.

Okuma HS, Fujiwara Y.

Clin Pharmacol Ther. 2019 May 23. doi: 10.1002/cpt.1453. [Epub ahead of print] No abstract available.

PMID:
31121054
15.

Azathioprine is Useful for Maintaining Long-term Remission Induced by Tacrolimus for the Treatment of Ulcerative Colitis: An Inverse Probability of a Treatment Weighing Analysis.

Nishida Y, Hosomi S, Yamagami H, Sugita N, Itani S, Yukawa T, Otani K, Nagami Y, Tanaka F, Taira K, Kamata N, Kakimoto K, Tanigawa T, Watanabe T, Fujiwara Y.

Intern Med. 2019 May 22. doi: 10.2169/internalmedicine.2632-19. [Epub ahead of print]

16.

Site-Selective Synthetic Acylation of a Target Protein in Living Cells Promoted by a Chemical Catalyst/Donor System.

Hamajima W, Fujimura A, Fujiwara Y, Yamatsugu K, Kawashima SA, Kanai M.

ACS Chem Biol. 2019 May 24. doi: 10.1021/acschembio.9b00102. [Epub ahead of print]

PMID:
31117394
17.

Bone marrow examination in patients with Ewing sarcoma/peripheral primitive neuroectodermal tumor without metastasis based on 18F-fluorodeoxyglucose positron emission tomography/computed tomography.

Inagaki C, Shimoi T, Sumiyoshi Okuma H, Kawachi A, Sudo K, Shimomura A, Noguchi E, Kodaira M, Yunokawa M, Yonemori K, Shimizu C, Arakawa A, Ogawa C, Yoshida A, Fujiwara Y, Tamura K.

Med Oncol. 2019 May 18;36(7):58. doi: 10.1007/s12032-019-1279-8.

PMID:
31104192
18.

Late start and insufficient S-1 dose in adjuvant chemotherapy can lead to poor prognosis in stage II/III gastric cancer.

Miyatani K, Saito H, Shimizu S, Kono Y, Murakami Y, Shishido Y, Matsunaga T, Fukumoto Y, Fujiwara Y.

Int J Clin Oncol. 2019 May 18. doi: 10.1007/s10147-019-01468-0. [Epub ahead of print]

PMID:
31104175
19.

Applications of MALDI mass spectrometry imaging for pharmacokinetic studies during drug development.

Nishidate M, Hayashi M, Aikawa H, Tanaka K, Nakada N, Miura SI, Ryu S, Higashi T, Ikarashi Y, Fujiwara Y, Hamada A.

Drug Metab Pharmacokinet. 2019 Apr 24. pii: S1347-4367(19)30059-X. doi: 10.1016/j.dmpk.2019.04.006. [Epub ahead of print] Review.

PMID:
31101590
20.

Expectations of and recommendations for a cancer survivorship guideline in Japan: a literature review of guidelines for cancer survivorship.

Okubo R, Wada S, Shimizu Y, Tsuji K, Hanai A, Imai K, Uchitomi Y, Fujiwara Y, Tsugane S, Matsuoka YJ.

Jpn J Clin Oncol. 2019 May 16. pii: hyz070. doi: 10.1093/jjco/hyz070. [Epub ahead of print]

PMID:
31095338
21.

Neutrophil-to-Lymphocyte Ratio as a Prognostic Indicator in Patients With Unresectable Gastric Cancer.

Murakami Y, Saito H, Shimizu S, Kono Y, Shishido Y, Miyatani K, Matsunaga T, Fukumoto Y, Fujiwara Y.

Anticancer Res. 2019 May;39(5):2583-2589. doi: 10.21873/anticanres.13381.

PMID:
31092456
22.

Clinical significance of preoperative chemoradiotherapy for advanced esophageal cancer, evaluated by propensity score matching and weighting of inverse probability of treatment.

Fujiwara Y, Fukuda S, Tsujie M, Kitani K, Yukawa M, Inoue M, Watanabe Y, Higashida M, Kubota H, Okada T, Tsuruta A, Ueno T.

Mol Clin Oncol. 2019 Jun;10(6):575-582. doi: 10.3892/mco.2019.1843. Epub 2019 Apr 12.

23.
24.

A Novel Prognostic Score Combining Preoperative Biliary Drainage and Inflammatory Status for Patients with Periampullary Cancers.

Fujiwara Y, Haruki K, Hamura R, Horiuchi T, Shirai Y, Furukawa K, Gocho T, Shiba H, Yanaga K.

J Gastrointest Surg. 2019 May 6. doi: 10.1007/s11605-019-04216-x. [Epub ahead of print]

PMID:
31062271
25.

Use of esophageal stent for the treatment of postoperative gastrointestinal-airway fistula after esophagectomy.

Okamoto K, Ninomiya I, Fujiwara Y, Mochizuki I, Aoki T, Yamaguchi T, Terai S, Nakanuma S, Kinoshita J, Makino I, Nakamura K, Miyashita T, Tajima H, Takamura H, Fushida S, Ohta T.

Esophagus. 2019 May 6. doi: 10.1007/s10388-019-00673-0. [Epub ahead of print]

PMID:
31062120
26.

Score of the preoperative absolute number of lymphocytes, monocytes, and neutrophils as a prognostic indicator for patients with gastric cancer.

Saito H, Shimizu S, Kono Y, Murakami Y, Shishido Y, Miyatani K, Matsunaga T, Fukumoto Y, Ashida K, Fujiwara Y.

Surg Today. 2019 May 6. doi: 10.1007/s00595-019-01817-6. [Epub ahead of print]

PMID:
31062094
27.

Detachable Snare to Fix the Endoscopic Nasobiliary Drainage Tube for the Treatment of Postoperative Bile Leakage.

Maruyama H, Kakiya-Ishikawa Y, Kinoshita Y, Tanoue K, Hayashi K, Yamamura M, Fujiwara Y.

Am J Gastroenterol. 2019 May;114(5):707. doi: 10.14309/ajg.0000000000000236. No abstract available.

PMID:
31058678
28.

Impact of Hepatitis Virus on the Feasibility and Efficacy of Anticancer Agents in Patients With Hepatocellular Carcinoma in Phase I Clinical Trials.

Koyama T, Kondo S, Shimizu T, Fujiwara Y, Morizane C, Sakamoto Y, Okusaka T, Yamamoto N.

Front Oncol. 2019 Apr 18;9:301. doi: 10.3389/fonc.2019.00301. eCollection 2019.

29.

Predictive factors of difficulty of thoracoscopic esophagectomy in the left decubitus position.

Fujiwara Y, Lee S, Gyobu K, Inazu D, Naka R, Nishiyama M, Ohira M, Osugi H.

Esophagus. 2019 Jul;16(3):316-323. doi: 10.1007/s10388-019-00663-2. Epub 2019 Apr 30.

PMID:
31041586
30.

Comprehensive behavioral study of the effects of vanillin inhalation in mice.

Ueno H, Shimada A, Suemitsu S, Murakami S, Kitamura N, Wani K, Takahashi Y, Matsumoto Y, Okamoto M, Fujiwara Y, Ishihara T.

Biomed Pharmacother. 2019 Jul;115:108879. doi: 10.1016/j.biopha.2019.108879. Epub 2019 Apr 28.

31.

Tumor expression and usefulness as a biomarker of programmed death ligand 1 in advanced non-small cell lung cancer patients with preexisting interstitial lung disease.

Shibaki R, Murakami S, Matsumoto Y, Goto Y, Kanda S, Horinouchi H, Fujiwara Y, Yamamoto N, Motoi N, Kusumoto M, Yamamoto N, Ohe Y.

Med Oncol. 2019 Apr 27;36(6):49. doi: 10.1007/s12032-019-1274-0.

PMID:
31030326
32.

Next-Generation Sequencer Analysis of Pulmonary Pleomorphic Carcinoma With a CD74-ROS1 Fusion Successfully Treated With Crizotinib.

Mizuno T, Fujiwara Y, Yoshida K, Kohno T, Ohe Y.

J Thorac Oncol. 2019 May;14(5):e106-e108. doi: 10.1016/j.jtho.2019.01.005. No abstract available.

PMID:
31027745
33.

Pathway from gait speed to incidence of disability and mortality in older adults: A mediating role of physical activity.

Abe T, Kitamura A, Taniguchi Y, Amano H, Seino S, Yokoyama Y, Nishi M, Narita M, Ikeuchi T, Fujiwara Y, Shinkai S.

Maturitas. 2019 May;123:32-36. doi: 10.1016/j.maturitas.2019.02.002. Epub 2019 Feb 7.

PMID:
31027674
34.

Radiologic features of pneumonitis associated with nivolumab in non-small-cell lung cancer and malignant melanoma.

Baba T, Sakai F, Kato T, Kusumoto M, Kenmotsu H, Sugiura H, Tominaga J, Oikado K, Sata M, Endo M, Yanagawa N, Sasaki S, Iwasawa T, Saito Y, Fujiwara Y, Ohe Y, Yamazaki N, Sakamoto T, Koshiba T, Kuwano K.

Future Oncol. 2019 Jun;15(16):1911-1920. doi: 10.2217/fon-2019-0102. Epub 2019 Apr 25.

35.

Can cognitive leisure activity prevent cognitive decline in older adults? A systematic review of intervention studies.

Iizuka A, Suzuki H, Ogawa S, Kobayashi-Cuya KE, Kobayashi M, Takebayashi T, Fujiwara Y.

Geriatr Gerontol Int. 2019 Jun;19(6):469-482. doi: 10.1111/ggi.13671. Epub 2019 Apr 24. Review.

PMID:
31020777
36.

Salvage Haploidentical Transplantation Using Low-dose ATG for Early Disease Relapse after First Allogeneic Transplantation: A Retrospective Single-center Review.

Okamoto S, Matsuoka KI, Sakamoto M, Usui Y, Fujiwara Y, Kondo T, Tani K, Saeki K, Meguri Y, Asada N, Ennishi D, Nishimori H, Fujii K, Fujii N, Maeda Y.

Acta Med Okayama. 2019 Apr;73(2):161-171. doi: 10.18926/AMO/56652.

37.

Poor Social Network, Not Living Alone, Is Associated With Incidence of Adverse Health Outcomes in Older Adults.

Sakurai R, Kawai H, Suzuki H, Kim H, Watanabe Y, Hirano H, Ihara K, Obuchi S, Fujiwara Y.

J Am Med Dir Assoc. 2019 Apr 9. pii: S1525-8610(19)30247-6. doi: 10.1016/j.jamda.2019.02.021. [Epub ahead of print]

PMID:
31000349
38.

Is unwilling volunteering protective for functional decline? The interactive effects of volunteer willingness and engagement on health in a 3-year longitudinal study of Japanese older adults.

Nonaka K, Fujiwara Y, Watanabe S, Ishizaki T, Iwasa H, Amano H, Yoshida Y, Kobayashi E, Sakurai R, Suzuki H, Kumagai S, Shinkai S, Suzuki T.

Geriatr Gerontol Int. 2019 Apr 16. doi: 10.1111/ggi.13667. [Epub ahead of print]

PMID:
30993862
39.

Pharmacokinetic study of the oral fluorouracil antitumor agent S-1 in patients with impaired renal function.

Goto K, Fujiwara Y, Isobe T, Chayahara N, Kiyota N, Mukohara T, Tsubata Y, Hotta T, Tamura K, Yamamoto N, Minami H.

Cancer Sci. 2019 Jun;110(6):1987-1994. doi: 10.1111/cas.14025. Epub 2019 May 11.

40.

Combined preoperative platelet-to-lymphocyte ratio and serum carbohydrate antigen 19-9 level as a prognostic factor in patients with resected pancreatic cancer.

Sakamoto T, Saito H, Amisaki M, Tokuyasu N, Honjo S, Fujiwara Y.

Hepatobiliary Pancreat Dis Int. 2019 Jun;18(3):278-284. doi: 10.1016/j.hbpd.2019.03.010. Epub 2019 Apr 5.

PMID:
30987900
41.

Intramucosal esophageal neuroendocrine carcinoma treated with endoscopic submucosal dissection and chemotherapy.

Ishikawa-Kakiya Y, Nagami Y, Fujiwara Y.

Dig Endosc. 2019 Apr 12. doi: 10.1111/den.13420. [Epub ahead of print] No abstract available.

PMID:
30977209
42.

Importance of prognostic stratification via gene mutation analysis in elderly patients with acute myelogenous leukemia.

Fujiwara Y, Yamaguchi H, Yui S, Tokura T, Inai K, Onai D, Omori I, Marumo A, Yamanaka S, Sakaguchi M, Terada K, Nakagome S, Arai K, Kitano T, Okabe M, Okamoto M, Tamai H, Nakayama K, Tajika K, Wakita S, Inokuchi K.

Int J Lab Hematol. 2019 Apr 10. doi: 10.1111/ijlh.13025. [Epub ahead of print]

PMID:
30970181
43.

Prognostic Value of Combined Tumor Marker and Controlling Nutritional Status (CONUT) Score in Colorectal Cancer Patients.

Yamamoto M, Saito H, Uejima C, Tanio A, Tada Y, Matsunaga T, Sakamoto T, Honjo S, Ashida K, Fujiwara Y.

Yonago Acta Med. 2019 Mar 28;62(1):124-130. eCollection 2019 Mar.

44.

Compressed Amplatzer Vascular Plug II Embolization of the Left Subclavian Artery for Thoracic Endovascular Aortic Repair is Efficient and Safety Method Comparable to Conventional Coil Embolization.

Matsumoto K, Ohuchi Y, Yata S, Adachi A, Endo M, Takasugi S, Fujii S, Hashimoto M, Kaminou T, Ogawa T, Fujiwara Y, Saiki M, Nishimura M.

Yonago Acta Med. 2019 Mar 28;62(1):24-29. eCollection 2019 Mar.

45.

Association between endoscopic findings of eosinophilic esophagitis and responsiveness to proton pump inhibitors.

Sawada A, Hashimoto A, Uemura R, Otani K, Tanaka F, Nagami Y, Yamagami H, Tanigawa T, Watanabe T, Fujiwara Y.

Endosc Int Open. 2019 Apr;7(4):E433-E439. doi: 10.1055/a-0859-7276. Epub 2019 Mar 21.

46.

A Comparative Study of Longitudinal Toxicities of Cytotoxic Drugs, Molecularly Targeted Agents, Immunomodulatory Drugs, and Cancer Vaccines.

Hirakawa A, Sudo K, Yonemori K, Sadachi R, Kinoshita F, Kobayashi Y, Okuma HS, Kawachi A, Tamura K, Fujiwara Y, Rubinstein L, Takebe N.

Clin Pharmacol Ther. 2019 Mar 30. doi: 10.1002/cpt.1442. [Epub ahead of print]

PMID:
30927439
47.

Zinc finger domain of the human DTX protein adopts a unique RING fold.

Miyamoto K, Fujiwara Y, Saito K.

Protein Sci. 2019 Jun;28(6):1151-1156. doi: 10.1002/pro.3610. Epub 2019 Apr 12.

PMID:
30927328
48.

Obesity and hiatal hernia may be non-allergic risk factors for esophageal eosinophilia in Japanese adults.

Tanaka F, Fukumoto S, Morisaki T, Otani K, Hosomi S, Nagami Y, Kamata N, Taira K, Nakano A, Kimura T, Yamagami H, Tanigawa T, Morikawa H, Watanabe T, Kawada N, Hirata K, Fujiwara Y.

Esophagus. 2019 Jul;16(3):309-315. doi: 10.1007/s10388-019-00662-3. Epub 2019 Mar 29.

PMID:
30927164
49.

[The influence of types of living alone on 2-year health changes according to elderly adults' marital status: Based on the Comprehensive Regional Studies for Preventing Isolation of the Elderly Who Live in Metropolitan Area (CAPITAL Study)].

Hashimoto Y, Watanabe S, Nonaka K, Koike T, Hasebe M, Murayama Y, Suzuki H, Fukaya T, Kobayashi E, Fujiwara Y.

Nihon Koshu Eisei Zasshi. 2019;66(3):129-137. doi: 10.11236/jph.66.3_129. Japanese.

50.

Response to the letter by Sumida et al. regarding our manuscript "Evaluation of ballooned hepatocytes as a risk factor for future progression of fibrosis in patients with non-alcoholic fatty liver disease".

Kakisaka K, Suzuki Y, Fujiwara Y, Abe T, Yonezawa M, Kuroda H, Ishida K, Sugai T, Takikawa Y.

J Gastroenterol. 2019 May;54(5):476-477. doi: 10.1007/s00535-019-01574-w. Epub 2019 Mar 26. No abstract available.

PMID:
30915534

Supplemental Content

Loading ...
Support Center